-
C01577-10
Thomas Scientific
dATP (100 mM) Greater/Equ99% HPLC,10ml (10.0ml/vial)
Price: $709.71List Price: $788.57dATP (100 mM) &ge99% HPLC -
C01577-1
Thomas Scientific
dATP (100 mM) Greater/Equ99% HPLC,1ml(1.0ml/vial)
Price: $121.56List Price: $135.06dATP (100 mM) &ge99% HPLC -
C01577-250
Thomas Scientific
dATP (100 mM) Greater/Equ99% HPLC,250ml (250.0ml/bottle)
Price: $14,217.03List Price: $15,796.70dATP (100 mM) &ge99% HPLC -
C01577-50
Thomas Scientific
dATP (100 mM) Greater/Equ99% HPLC,50ml (50ml/bottle)
Price: $3,032.97List Price: $3,369.96dATP (100 mM) &ge99% HPLC -
10005188-100A fluorescent fatty acid analog that alters its fluorescent emission spectra and intensity on entry into binding proteins.
-
10005188-25A fluorescent fatty acid analog that alters its fluorescent emission spectra and intensity on entry into binding proteins.
-
10005188-50A fluorescent fatty acid analog that alters its fluorescent emission spectra and intensity on entry into binding proteins.
-
M00630Programmed cell death protein 1, also known as PD-1 and CD279 (cluster of differentiation 279), is a protein that in humans is encoded by the PDCD1 gene. PD-1, functioning as an immune checkpoint, plays an important role in down regulating the
-
14159-10An antitumor antibiotic that induces apoptosis in mature monocytic U937 and myelocytic HL-60 acute myeloid leukemia cells at 0.2-1 &muM triggers a ROS-dependent sphingomyelin-ceramide pathway that activates the MEKK1-SEK1-JNK.
-
14159-100An antitumor antibiotic that induces apoptosis in mature monocytic U937 and myelocytic HL-60 acute myeloid leukemia cells at 0.2-1 &muM triggers a ROS-dependent sphingomyelin-ceramide pathway that activates the MEKK1-SEK1-JNK.
-
14159-5An antitumor antibiotic that induces apoptosis in mature monocytic U937 and myelocytic HL-60 acute myeloid leukemia cells at 0.2-1 &muM triggers a ROS-dependent sphingomyelin-ceramide pathway that activates the MEKK1-SEK1-JNK.
-
14159-50An antitumor antibiotic that induces apoptosis in mature monocytic U937 and myelocytic HL-60 acute myeloid leukemia cells at 0.2-1 &muM triggers a ROS-dependent sphingomyelin-ceramide pathway that activates the MEKK1-SEK1-JNK.